Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease

References

• Abdulle S, Hagberg L, Gisslén M. Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients. HIV Med 2005; 6: 164–169
   PubMed Web of Science ®Google Scholar
• Arendt G, Hefter H, Elsing C, Strohmeyer G, Freund H J. Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit. J Neurol 1990; 237: 362–368
   PubMed Web of Science ®Google Scholar
• Bestetti A, Presi S, Pienotti C, Bossolasco S, Sala S, Racca S, Carrera P, Lazzarin A, Cinque P. Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance. J NeuroVirol 2004; 10: 52–57, (Suppl 1)
   Google Scholar
• Brew B, Pemberton L, Cunningham P, Law M. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Inf Dis 1997; 175: 963–966
   PubMed Web of Science ®Google Scholar
• CDC. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269(6)729–730
   Google Scholar
• Chiodi F, Keys B, Albert J, Hagberg L, Lundeberg J, Uhlen M, Fenyo E M, Norkrans G. Human immunodeficiency virus type I is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol 1992; 30: 1768–1771
   PubMed Web of Science ®Google Scholar
• Cinque P, Sestetti A, Morelli P, Presi S. Molecular analysis of cerebrospinal fluid: Potential for the study of HIV-1 infection of the central nervous system. J NeuroVirol 2000; 6: 95–102, (Suppl 1)
   PubMed Web of Science ®Google Scholar
• De Luca A, Ciancio B C, Larussa D, Murri R, Cingolati A, Rizzo M G, Giancola M L, Ammassari A, Ortona L. Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals. Neurology 2002; 59: 342–347
   PubMed Web of Science ®Google Scholar
• Ellis R J, Childers M E, Zimmerman J D, Frost S D, Deutsch R, McCutchan J A. Human immunodeficiency virus-l RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy. J Infect Dis 2003; 187: 1818–1821
   Google Scholar
• Ellis R, Gamst A, Capparelli E, Spector S, Hisa K, Wolfson T, Abramson I, Grant I, McCutchan Hsic. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 2000; 54: 927–936
   PubMed Web of Science ®Google Scholar
• Ellis R J, Hsia K, Spector S A, Nelson J A, Heaton R K, Wallace M R, Abramson I, Atkinson J H, Grant I, McCutchan J A. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group [see comments]. Ann Neurol 1997; 42: 679–688
   PubMed Web of Science ®Google Scholar
• Garcia F, Niebla G, Romeu J, Vidal C, Plana M, Ortega M, Ruiz L, Gallart T, Clotet B, Miro J M. Cerebrospinal fluid HIV-l RNA levels in asymptomatic patients with early stage chronic HIV-l infection: support for the hypothesis of local virus replication. AIDS 1999; 13: 1491–1496
   PubMed Web of Science ®Google Scholar
• Gartner S. HIV infection and dementia. Science 2000; 287: 602–604
   PubMed Web of Science ®Google Scholar
• Giancola M L, Lorenzini P, Balestra P, Larussa D, Baldini F, Corpolongo A, Narciso P, Bellagamba R, Tozzi V, Antinori A. Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 41: 332–337
   PubMed Web of Science ®Google Scholar
• von Giesen H J, Adams O, Koller H, Arendt G. Cerebrospinal fluid HIV viral load in different phases of HIV-associated brain disease. J Neurol 2005; 252: 801–807
   Google Scholar
• von Giesen H J, Hefter H, Roick H, Mauss S, Arendt G. HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers. J Neurol 1994; 242: 20–25
   PubMed Web of Science ®Google Scholar
• Gisslén M, Fuchs D, Svennerholm B, Hagberg L. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-l infection. J Acquir Immune Defic Syndr 1999; 21: 271–276
   PubMed Web of Science ®Google Scholar
• Gisslén M, Hagberg L, Fuchs D, Norkrans G, Svennerholm B. Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 291–295
   Google Scholar
• Harrington P R, Haas D W, Ritola K, Swanstrom R. Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells. J Virol 2005; 79: 7959–7966
   PubMed Web of Science ®Google Scholar
• 1Klove H. Clinical neuropsychology. Saunders, New York 1963
   Google Scholar
• Korber B T, Kunstmann K J, Patterson B K, Furtado M, McEvilly M M, Levy R, Wolinsky S M. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein brain-derived sequences. J Virol 1994; 68: 7467–7481
   PubMed Web of Science ®Google Scholar
• Lambotte O, Deiva K, Tardieu M. HIV-l persistence, viral reservoir, and the central nervous system in the HAART era. Brain Pathol 2003; 13: 95–103
   PubMed Web of Science ®Google Scholar
• Marshall D, Brey R, Cahill W, Houk R, Zajac R, Boswell R. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988; 45: 954–958
   PubMedGoogle Scholar
• Martin C, Albert J, Hansson P, Pehrsson P, Link H, Sonnerborg A. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-l RNA levels. J Acquir Immun Def Syndr Human Retrovirol 1998; 17: 214–219
   PubMedGoogle Scholar
• McArthur J C, McClemon D R, Cronin M F, Nance-Sproson T E, Saah A J, St Clair M, Lanier E R. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain [see comments]. Ann Neurol 1997; 42: 689–698
   PubMed Web of Science ®Google Scholar
• Monteiro d e, Almeida S, Letendre S, Zimmerman J, Lazzaretto D, McCutchan A, Ellis R. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. J Neuroimmunol 2005; 169: 144–152
   Google Scholar
• Neuenburg J K, Sinclair E, Nilsson A, Kreis C, Bacchetti P, Price R W, Grant R M. HIV-producing T cells in cerebrospinal fluid. J Acquir Immune Defic Syndr 2004; 37: 1237–1244
   Google Scholar
• Peeters M F, Colebunders R L, Van den Abbeele K, Nys P C, Goeman J, Colans P, Geerts Y, Van den Groen G. Comparison of human immunodeficiency virus biological phenotypes isolated from cerebrospinal fluid and peripheral blood. J Med Virol 1995; 47: 92–96
   Google Scholar
• Price R W. The two faces of HIV infection of cerebrospinal fluid. Trends Microbiol 2000; 8: 387–391
   Google Scholar
• 2Price R W, Staprans S. Measuring the “viral load” in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection?. Ann Neurol l997; 42: 675–678
   Google Scholar
• 1Price R W, Yiannoutsos C T, Clifford D B, Zaborski L, Tselis A, Sidtis J J, Cohen B, Hall C D, Erice A, Henry K. Neurological outcomes in late HIV infection: Adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS 1999; 13: 1677–1685
   PubMed Web of Science ®Google Scholar
• 2Reitan R M, Wolfson D. 1985
   Google Scholar
• Sacktor N C, Lyles R H, Skolasky R L, Anderson D E, McArthur J C, McFarlane G, Selnes O A, Becker J T, Cohen B, Wesch J, Miller E N. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 1999; 52: 1640–1647
   PubMed Web of Science ®Google Scholar
• Scheller C, Sopper S, Jenuwein M, Neuen-Jacob E, Tatschner T, Grunblatt E, ter Meulen V, Riederer P, Koutsilieri E. Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation. J Neurochem 2005; 95: 377–387
   Google Scholar
• Sevigny J J, Albert S M, McDermott M P, McArthur J C, Sacktor N, Conant K, Schifitto G, Selnes O A, Stern Y, McClernon D R, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein L G, Marder K. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 2004; 63: 2084–2090
   PubMed Web of Science ®Google Scholar
• Siliciano J D, Siliciano R F. A long-term latent reservoir for HIV-l: discovery and clinical implications. J Antimicrob Chemother 2004; 54: 6–9
   PubMed Web of Science ®Google Scholar
• Spector S A, Hsia K, Pratt D, Lathey J, McCutchan J A, Alcaraz J E, Atkinson J H, Gulevich S, Wallace M, Grant I. Virological markers of human immunodeficiency virus type I in cerebrospinal fluid. The HIV Neurobehavioral Research Center Group. J Infect Dis 1993; 168: 68–74
   Google Scholar
• Spreen O, Strauss E. A compendium of neuropsychological tests, 2nd edition. Oxford University Press, New York 1998
   Google Scholar
• Spudich S S, Lollo N D, Liegler T, Deeks S TG, Price R W. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure. JID 2006; 194: 1686–1696
   Google Scholar
• Spudich S S, Nilsson A C, Lollo N D, Liegler T J, Petropoulos C J, Deeks S G, Paxinos E E, Price R W. Cerebrospinal fluid HIV infection and pleocytosis: Relation to systemic infection and antiretroviral treatment. BMC Infect Dis 2005; 5: 98
   PubMedGoogle Scholar
• Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant R M, Heyes M, Aweeka F, Deeks S, Price R W. Time course of cerebrospinal fluid responses to antiretroviral therapy: Evidence for variable compartmentalization of infection. AIDS 1999; 13: 1051–1061
   PubMed Web of Science ®Google Scholar
• Stingele K, Haas J, Zimmermann T, Stingele R, Hubsch-Muller C, Freitag M, Storch-Hagenlocher B, Hartmann M, Wildemann B. Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology 2001; 56: 355–361
   Google Scholar